SL
BIIB icon

Sentry LLC’s Biogen BIIB Stock Holding History

Sentry LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-873
Closed -$202K – 129
2024
Q2 		$202K Buy
+873
New +$190K 0.04% 121
2024
Q1 		– Sell
-938
Closed -$243K – 127
2023
Q4 		$243K Sell
938
-535
-36% -$131K 0.05% 104
2023
Q3 		$379K Hold
1,473
– – 0.08% 76
2023
Q2 		$420K Hold
1,473
– – 0.09% 77
2023
Q1 		$410K Buy
+1,473
New +$408K 0.1% 78

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sentry LLC's BIIB Position: Q3 2024 in Review

Sentry LLC sold out of Biogen (BIIB) in Q3 2024, closing a stake of 873 shares — an estimated $202K sold.

Sentry LLC first reported a position in BIIB in Q1 2023 and held it in 5 quarters. The position peaked at $420K in Q2 2023. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Sentry LLC reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Sentry LLC sold 873 Biogen shares in Q3 2024, an estimated $202K.
  • Sentry LLC first reported a position in Biogen in Q1 2023 and held it in 5 quarters.
  • Sentry LLC's Biogen position peaked at $420K in Q2 2023.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Sentry LLC's 13F filing for Q3 2024, filed 15 Oct 2024.